Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Safety and efficacy of endovascular sonolysis using the EkoSonic endovascular system in patients with acute stroke

M. Kuliha, M. Roubec, T. Jonszta, J. Krajca, D. Czerny, A. Krajina, K. Langová, R. Herzig, V. Procházka, D. Školoudík,

. 2013 ; 34 (7) : 1401-1406.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14040936

Grantová podpora
NT11386 MZ0 CEP - Centrální evidence projektů
NT11046 MZ0 CEP - Centrální evidence projektů

BACKGROUND AND PURPOSE: Sonolysis is a new therapeutic procedure for arterial recanalization. The aim of this study was to confirm the safety and efficacy of endovascular sonolysis by using the EkoSonic Endovascular System in subjects with acute ischemic stroke. MATERIALS AND METHODS: Patients with acute ischemic stroke with occlusion of the middle cerebral artery or basilar artery were enrolled consecutively in this prospective study. The control group (44 MCA and 12 BA occlusions) was selected from historical controls. EkoSonic Endovascular System was started within 8 hours after stroke onset. The NIHSS score at hospital admission, after 24 hours, and at 7 days; arterial recanalization; early neurologic improvement; symptomatic intracerebral hemorrhage; and favorable 3-month clinical outcome defined as a modified Rankin Scale score of 0-2 were evaluated by statistical means. RESULTS: Fourteen patients (10 men; mean age, 65.1 ± 11.2 years; median NIHSS score, 16.5) underwent EkoSonic endovascular sonolysis. Arterial recanalization after endovascular treatment was achieved in 6 of 7 (85.7%) patients with MCA occlusion (4 complete recanalizations) and in all 7 (100%) patients with BA occlusion (6 complete recanalizations). No (0%) symptomatic intracerebral hemorrhage or periprocedural complications occurred. Seven (50%) patients were independent at 3 months (median mRS score, 2). Early neurologic improvement and favorable clinical outcome were significantly more frequent in patients with MCA occlusion undergoing EkoSonic endovascular sonolysis than in controls (100% and 71.4% versus 4.6% and 13.6% of patients; P = .0001 and P = .003, respectively). Three-month mortality was significantly lower in patients with BA occlusion undergoing EkoSonic endovascular sonolysis than in controls (0% versus 66.7% patients, P = .013). CONCLUSIONS: In this small study, EkoSonic endovascular sonolysis allowed safe and potentially effective revascularization in patients experiencing acute ischemic stroke.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14040936
003      
CZ-PrNML
005      
20240220115811.0
007      
ta
008      
140107s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.3174/ajnr.A3416 $2 doi
035    __
$a (PubMed)23370469
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kuliha, Martin $7 xx0313290
245    10
$a Safety and efficacy of endovascular sonolysis using the EkoSonic endovascular system in patients with acute stroke / $c M. Kuliha, M. Roubec, T. Jonszta, J. Krajca, D. Czerny, A. Krajina, K. Langová, R. Herzig, V. Procházka, D. Školoudík,
520    9_
$a BACKGROUND AND PURPOSE: Sonolysis is a new therapeutic procedure for arterial recanalization. The aim of this study was to confirm the safety and efficacy of endovascular sonolysis by using the EkoSonic Endovascular System in subjects with acute ischemic stroke. MATERIALS AND METHODS: Patients with acute ischemic stroke with occlusion of the middle cerebral artery or basilar artery were enrolled consecutively in this prospective study. The control group (44 MCA and 12 BA occlusions) was selected from historical controls. EkoSonic Endovascular System was started within 8 hours after stroke onset. The NIHSS score at hospital admission, after 24 hours, and at 7 days; arterial recanalization; early neurologic improvement; symptomatic intracerebral hemorrhage; and favorable 3-month clinical outcome defined as a modified Rankin Scale score of 0-2 were evaluated by statistical means. RESULTS: Fourteen patients (10 men; mean age, 65.1 ± 11.2 years; median NIHSS score, 16.5) underwent EkoSonic endovascular sonolysis. Arterial recanalization after endovascular treatment was achieved in 6 of 7 (85.7%) patients with MCA occlusion (4 complete recanalizations) and in all 7 (100%) patients with BA occlusion (6 complete recanalizations). No (0%) symptomatic intracerebral hemorrhage or periprocedural complications occurred. Seven (50%) patients were independent at 3 months (median mRS score, 2). Early neurologic improvement and favorable clinical outcome were significantly more frequent in patients with MCA occlusion undergoing EkoSonic endovascular sonolysis than in controls (100% and 71.4% versus 4.6% and 13.6% of patients; P = .0001 and P = .003, respectively). Three-month mortality was significantly lower in patients with BA occlusion undergoing EkoSonic endovascular sonolysis than in controls (0% versus 66.7% patients, P = .013). CONCLUSIONS: In this small study, EkoSonic endovascular sonolysis allowed safe and potentially effective revascularization in patients experiencing acute ischemic stroke.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a angioplastika $x metody $7 D017130
650    _2
$a ischemie mozku $x terapie $7 D002545
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a revaskularizace mozku $x přístrojové vybavení $x metody $7 D002548
650    _2
$a endovaskulární výkony $x metody $7 D057510
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibrinolytika $x terapeutické užití $7 D005343
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a infarkt arteria cerebri media $x terapie $7 D020244
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mechanická trombolýza $x přístrojové vybavení $x metody $7 D061185
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neurologické vyšetření $7 D009460
650    _2
$a prospektivní studie $7 D011446
650    _2
$a obnova funkce $x fyziologie $7 D020127
650    _2
$a recidiva $7 D012008
650    _2
$a bezpečnost $7 D012449
650    _2
$a vibrace ultrazvukové $x přístrojové vybavení $x metody $7 D013010
650    _2
$a stenty $7 D015607
650    _2
$a cévní mozková příhoda $x terapie $7 D020521
650    _2
$a míra přežití $7 D015996
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a vertebrobazilární insuficience $x terapie $7 D014715
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Roubec, Martin $7 xx0231427
700    1_
$a Jonszta, Tomáš $7 xx0130700
700    1_
$a Krajča, Jan $7 xx0234711
700    1_
$a Czerný, Daniel $7 xx0130698
700    1_
$a Krajina, Antonín, $d 1958- $7 nlk20050172885
700    1_
$a Langová, K
700    1_
$a Herzig, Roman, $d 1968- $7 mzk2007411122
700    1_
$a Procházka, V
700    1_
$a Školoudík, David, $d 1972- $7 xx0020614
773    0_
$w MED00009116 $t American journal of neuroradiology $x 1936-959X $g Roč. 34, č. 7 (2013), s. 1401-1406
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23370469 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140107 $b ABA008
991    __
$a 20240220115808 $b ABA008
999    __
$a ok $b bmc $g 1005332 $s 839448
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 34 $c 7 $d 1401-1406 $i 1936-959X $m American journal of neuroradiology $n AJNR Am J Neuroradiol $x MED00009116
GRA    __
$a NT11386 $p MZ0
GRA    __
$a NT11046 $p MZ0
LZP    __
$a Pubmed-20140107

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...